Antibodies

31 Mar 2020 I-Mab Submits IND Application to Initiate Study of TJM2 for Treatment of Cytokine Storm Associated with Severe COVID-19 in South Korea
31 Mar 2020 GigaGen Initiates Development of Recombinant Polyclonal Antibody Therapy for COVID-19
31 Mar 2020 Mersana Therapeutics Reports Updated Data from the XMT-1536 Phase 1 Dose Escalation Study
30 Mar 2020 Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
30 Mar 2020 First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
30 Mar 2020 Imfinzi approved in the US for extensive-stage small cell lung cancer
30 Mar 2020 Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept
29 Mar 2020 Novartis Cosentyx® gains positive CHMP opinion for new indication in the axial spondyloarthritis spectrum
27 Mar 2020 Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma
27 Mar 2020 Bolt Biotherapeutics Announces Initiation of BDC-1001 Clinical Trial in Patients with HER2-Expressed Solid Tumors
26 Mar 2020 First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy
26 Mar 2020 Eisai submits marketing authorization application in Japan for anticancer agent denileukin diftitox (genetic recombinant) for cutaneous T-cell lymphoma and peripheral T-cell lymphoma
26 Mar 2020 Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend XmAb Antibody Technology in Investigational Antibodies to Treat COVID-19
26 Mar 2020 Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
25 Mar 2020 ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer
25 Mar 2020 Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies
24 Mar 2020 Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients with Advanced Urothelial Carcinoma (COAXIN)
24 Mar 2020 Sorrento collaborates with Mabpharm on development and commercialization of ACE-MAB™ to potentially treat COVID-19
23 Mar 2020 Celltrion Accelerates Development of COVID-19 Antiviral Treatment and Aims to Launch Rapid Self-testing Kit
23 Mar 2020 Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia
20 Mar 2020 Sorrento develops STI-4398 (COVIDTrap™ protein) for potential prevention and treatment of SARS-Cov-2 coronavirus disease (COVID-19)
20 Mar 2020 Junshi Biosciences Announces Co-Development Agreement with IMCAS to Advance Neutralizing Antibodies as Potential Novel Treatment for COVID-19
19 Mar 2020 Genentech Initiates Phase III Clinical Trial Of Actemra In Hospitalized Patients With Severe COVID-19 Pneumonia
19 Mar 2020 Roivant Announces Development of Anti-GM-CSF Monoclonal Antibody to Prevent and Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
18 Mar 2020 Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top